Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- initialism Human Epidermal growth factor Receptor 2
- noun oncology Receptor which is the target for the drug
trastuzumab inchemotherapy .
Etymologies
from Wiktionary, Creative Commons Attribution/Share-Alike License
Support
Help support Wordnik (and make this page ad-free) by adopting the word HER-2.
Examples
-
The formal name is “human epidermal growth factor receptor,” and it is also known as HER-2, c-erbB-2, ErbB-2, and ERBB2.
The 10 Best Questions Dede Bonner 2008
-
The formal name is “human epidermal growth factor receptor,” and it is also known as HER-2, c-erbB-2, ErbB-2, and ERBB2.
The 10 Best Questions Dede Bonner 2008
-
The Personalized Medicine Coalition, a nonprofit advocacy group including industry, academia and government organizations, estimated the cost of Herceptin therapy per patient at about $79,000 for those who weren't tested for HER-2 and were more likely to have a poorer response to the treatment.
Companies Aim to Personalize Therapy Goran Mijuk 2010
-
Targeted therapy with trastuzumab (Herceptin) can help the 20 percent of breast-cancer patients who have a protein called human epidermal growth factor receptor 2 (HER-2).
-
The HER-2 gene helps to control how cells grow, divide and repair themselves.
Companies Aim to Personalize Therapy Goran Mijuk 2010
-
Since it was established through the PathVysion test that her breast cancer was due to too much of the HER-2 gene, she was told to take Roche's Herceptin.
Companies Aim to Personalize Therapy Goran Mijuk 2010
-
If a tumor is present, the antibodies, with the nanoparticles in tow, naturally recognize and bind to the HER-2 receptor of breast-cancer cells.
Researchers Create Better Ways to Spot Cancer Cells Shirley S. Wang 2011
-
A key product, he says, is Abbott's PathVysion test, which measures the HER-2 gene, a primary target for the breast cancer drug Herceptin, made by Roche.
Companies Aim to Personalize Therapy Goran Mijuk 2010
-
Only 30% to 40% of breast cancers contain the HER-2 receptor, the target in the current experiment.
Researchers Create Better Ways to Spot Cancer Cells Shirley S. Wang 2011
-
But since it was clear that her cancer was due to the HER-2 gene, doctors kept treating her with Herceptin.
Companies Aim to Personalize Therapy Goran Mijuk 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.